electroCore (ECOR) Gross Profit Growth (3y) (2020 - 2026)
electroCore (ECOR) Gross Profit Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 9.03% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 17.49% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 1.49% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.15% |
| 10 | electroCore | 55,642.90 | -8.77 Mn | 8.36 Mn | 53.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.29% |
| Dec 31, 2025 | 62.05% |
| Sep 30, 2025 | 63.22% |
| Jun 30, 2025 | 52.99% |
| Mar 31, 2025 | 54.77% |
| Dec 31, 2024 | 71.54% |
| Sep 30, 2024 | 69.26% |
| Jun 30, 2024 | 80.93% |
| Mar 31, 2024 | 75.69% |
| Dec 31, 2023 | 234.47% |
| Sep 30, 2023 | 73.76% |
| Jun 30, 2023 | 83.51% |
| Mar 31, 2023 | 74.68% |
| Dec 31, 2022 | 89.05% |
| Sep 30, 2022 | 73.48% |
| Jun 30, 2022 | 69.67% |
| Mar 31, 2022 | 82.83% |
| Dec 31, 2021 | 89.81% |
| Sep 30, 2021 | 175.89% |
| Jun 30, 2021 | 80.28% |